Insider trades

P. Kent Hawryluk, CEO of MBX Biosciences MBX, has filed 3 purchases and 1 sale on the open market. Over the past 12 months that comes to a net purchase of $780.5K. The latest trade was on 05/06.

P. Kent Hawryluk

President & CEO
First filing
24/09/13
Trades
19 trades
Buys / sales
3 / 1
12-month net buying
$780.5K
Last trade
05/06

Trading activity

Transactions

Trade type
Open-market sale05/0605/08607 sh$29.54$17,930.78−0.1%
Open-market buy03/1303/1618,500 sh$28.41$525,585+4.0%
Open-market buy25/10/2025/10/2120,000 sh$13.64$272,800+4.5%
Open-market buy25/02/0425/02/0550,000 sh$10.69$534,500+12.6%